LOG IN
|
Services
|
Contact
|
Custom Research
Search
Advanced search
Main
Healthcare, Pharmaceuticals & Biotechnology
Healthcare and drugs
U.S. HIV/AIDS Therapeutic Markets
Publications
Business, Finance & Insurance
(35706)
Consumer Goods & Retail
(127031)
Databases & Statistics
(27)
Education & Consulting
(0)
Industry
(87698)
Healthcare, Pharmaceuticals & Biotechnology
(58540)
Biotechnology
(9100)
Pharmaceuticals
(30490)
Healthcare and drugs
(18950)
Services
(0)
Government and Public Sector
(553)
Technologies & Electronics
(91477)
Company reports
(70860)
Country reports
(2187)
(Currently 512486 Items)
Partners
Healthcare and drugs / REPORT INFORMATION
U.S. HIV/AIDS Therapeutic Markets
Date
Sep, 1999
Pages
0
Price / format
€3353 / Hard Copy
€2976 / Site License
€4106 / Enterprisewide
€2 951
Report Information
|
Custom-Tailored Research
|
Product Trade Lead
Abstract:
This report covers the markets for major HIV/AIDS drug therapies, including protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), and non-nucleoside reverse transcriptase inhibitors (NNRTIs). It also examines a range of emerging drugs and therapies. By evaluating challenges and presenting forecasts both by product and product type, this report offers its users a comprehensive guide to the HIV/AIDS drug markets. This report, which monitors industry changes and analyzes competitive strategies, can help your firm develop a winning plan of action. From Frost & Sullivan.
Table of contents:
- Executive Summary
- Introduction to the U.S. HIV/AIDS Therapeutics Market
- Summary of Major Findings
- Market Engineering Research Methodology
- Frost & Sullivan's 12-Step Market Engineering Research Methodology
- Frost & Sullivan'
Order this report
Company name:
Contact person:
Phone/fax:
Email:
Comments:
Product Trade Lead
0 leads found
Add New Buy/Sell Lead
Type:
Buy
Sell
Offer:
Contacts:
Capture:
© 2007-2010 MarketReportFinder.com